Why the study?
Does intravenous clonidine reduce sympathetic nervous activity and improve hemodynamics in patients with alcoholic cirrhosis?
Does intravenous clonidine reduce sympathetic nervous activity and improve hemodynamics in patients with alcoholic cirrhosis?
Intravenous clonidine reduces sympathetic nervous activity, lowers renal vascular resistance, and reduces portal venous pressure in patients with alcoholic cirrhosis.
This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE: To study disturbances in sympathetic nervous system function in patients with alcoholic cirrhosis and the effect of clonidine on such disturbances. DESIGN: Cross-sectional physiologic and neurochemical evaluation of patients with cirrhosis and of healthy controls; an uncontrolled trial of intravenous clonidine in the cirrhotic patients. PATIENTS: Forty-four hospitalized patients with biopsy-proven alcoholic cirrhosis and 31 healthy controls. INTERVENTIONS: Intravenous clonidine. MAIN OUTCOME MEASURES: Radiotracer-derived measures of norepinephrine release to plasma, central hemodynamics, wedge hepatic vein pressure, and measures of renal function. MAIN RESULTS: In patients with cirrhosis, clonidine reduced previously elevated norepinephrine overflow rates for the whole body, kidneys, and hepatomesenteric circulation. This sympathetic inhibition was accompanied by the following potentially clinically beneficial effects: the lowering of renal vascular resistance (median reduction, 24%; 95% CI, 14% to 31%), the elevation of glomerular filtration rate (median increase, 27%; CI, 14% to 39%), and the reduction of portal venous pressure (median reduction, 25%; CI, 18% to 32%). The norepinephrine and hemodynamic responses to graded clonidine dosing (1, 2, and 3 micrograms/kg body weight intravenously) indicated that the sympathetic outflow to the hepatomesenteric circulation was more sensitive to pharmacologic suppression with clonidine than was the sympathetic outflow to the systemic circulation. CONCLUSIONS: The sympathetic nerves to the kidneys, heart, and hepatomesenteric circulation are stimulated in patients with cirrhosis. Clonidine inhibits these activated sympathetic outflows differentially, which could possibly provide a basis for the selective pharmacologic treatment of portal hypertension in patients with cirrhosis.
Answers are grounded in this paper and cite their sources.
Supports investigation of clonidine for hemodynamics in alcoholic cirrhosis; leaves open outcome benefits pending randomized trials.
No takes yet. Share an insight, caveat, or question.
Esler et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: